Figure 6. Silencing Hsa_circ_0018818 inhibits NSCLC progression by inactivating EMT process and PI3K/Akt signaling. (A) Western blot analysis of NID1, E-cadherin, Vimentin, Twist-2, Akt, ERK, p-Akt and p-ERK expression in NCI-H1650 cells. (B–G) Relative levels of NID1, Vimentin, E-cadherin, Twist-2,p-Akt and p-ERK expression in NCI-H1650 cells normalized to β-actin expression. **P< 0.01 vs. control. ##P< 0.01 vs. shRNA1.